Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
Status:
Completed
Trial end date:
2018-02-18
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of two concentrations of PRT-2761 as a topical ophthalmic
solution for the treatment of the signs and symptoms of acute and chronic allergic
conjunctivitis.